Humacyte HUMA
NASDAQ HUMA
$0.68 -0.05 (-6.85%)
At close: Aug 20, 2026 · 4:00 PM EDT

Humacyte (HUMA) Return on Sales (2020 - 2026)

Humacyte (HUMA) posted quarterly Return on Sales of 0.62% for Q1 2026, down 13.0% year-over-year from 0.72% in Q1 2025, and up 5.9% quarter-over-quarter from 0.66% in Q4 2025.

Humacyte (HUMA) Return on Sales (2020 - 2026) Analysis & Trends

Humacyte (HUMA) has reported Return on Sales for 5 consecutive years, with 0.62% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Return on Sales fell 13.0% year-over-year to 0.62%; the TTM figure through Mar 2026 stood at 0.89% (up 138.0% YoY), while the FY2025 annual figure was 0.57%, changed N/A from the prior year.
  • Return on Sales rose to 0.62% in Q1 2026 per HUMA's latest filing, from 0.66% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.49% in Q1 2025 and bottomed at 4.97% in Q3 2024.
  • Historically, Return on Sales has averaged 1.42% across 3 years, with a median of 0.98% in 2024.
  • Annual changes were most pronounced in 2025 — Return on Sales surged 383 bps — and 2026, when it dropped 13 bps.
  • Humacyte's Return on Sales stood at 4.97% in 2024, then soared by 87 bps to 0.66% in 2025, then advanced by 6 bps to 0.62% in 2026.
  • Business Quant data shows HUMA's Return on Sales at 0.62% in Q1 2026, 0.66% in Q4 2025, and 1.14% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.00%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 0.00%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -0.05%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 0.00%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.00%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.00%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.00%
10 Humacyte 158.12 Mn 158.12 Mn -825,000.00 -0.71%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.71%
Mar 31, 2026 -0.62%
Dec 31, 2025 -0.66%
Sep 30, 2025 -1.14%
Jun 30, 2025 -1.04%
Mar 31, 2025 -0.49%
Sep 30, 2024 -4.97%
Jun 30, 2024 -0.98%
Sep 30, 2021 -1.31%
Sep 30, 2020 -0.19%